Literature DB >> 11170214

1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR.

B Pillai1, K K Kannan, M V Hosur.   

Abstract

Three-dimensional structure of an asymmetrically mutated (C95M) tethered human immunodeficiency virus type 1 protease enzyme (HIV-1 PR) has been determined in an unliganded form using X-ray diffraction data to 1.9 A resolution. The structure, refined using X-PLOR to an R factor of 19.5%, is unexpectedly similar to the ligand-bound native enzyme, rather than to the ligand-free native enzyme. In particular, the two flaps in the tethered dimer are in a closed configuration. The environments around M95 and C1095 are identical, showing no structural effect of this asymmetric mutation at position 95. Oxidation of Cys1095 has been observed for the first time. There is one well-defined water molecule that hydrogen bonds to both carboxyl groups of the essential aspartic acids in the active site. Proteins 2001;43:57-64. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170214     DOI: 10.1002/1097-0134(20010401)43:1<57::aid-prot1017>3.0.co;2-d

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  16 in total

1.  Crystal structure of HIV-1 protease in situ product complex and observation of a low-barrier hydrogen bond between catalytic aspartates.

Authors:  Amit Das; Vishal Prashar; Smita Mahale; L Serre; J-L Ferrer; M V Hosur
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 2.  Targeting structural flexibility in HIV-1 protease inhibitor binding.

Authors:  Viktor Hornak; Carlos Simmerling
Journal:  Drug Discov Today       Date:  2006-12-20       Impact factor: 7.851

3.  Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants.

Authors:  Ravikiran S Yedidi; Georghe Proteasa; Jorge L Martinez; John F Vickrey; Philip D Martin; Zdzislaw Wawrzak; Zhigang Liu; Iulia A Kovari; Ladislau C Kovari
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-05-17

4.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

Review 5.  Linkers in the structural biology of protein-protein interactions.

Authors:  Vishnu Priyanka Reddy Chichili; Veerendra Kumar; J Sivaraman
Journal:  Protein Sci       Date:  2013-01-08       Impact factor: 6.725

6.  Small molecule regulation of protein conformation by binding in the Flap of HIV protease.

Authors:  Theresa Tiefenbrunn; Stefano Forli; Michael M Baksh; Max W Chang; Meaghan Happer; Ying-Chuan Lin; Alexander L Perryman; Jin-Kyu Rhee; Bruce E Torbett; Arthur J Olson; John H Elder; M G Finn; C David Stout
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

7.  Observation of a tetrahedral reaction intermediate in the HIV-1 protease-substrate complex.

Authors:  Mukesh Kumar; Vishal Prashar; Smita Mahale; Madhusoodan V Hosur
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

8.  Protein pharmacophore selection using hydration-site analysis.

Authors:  Bingjie Hu; Markus A Lill
Journal:  J Chem Inf Model       Date:  2012-03-26       Impact factor: 4.956

9.  The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor.

Authors:  Matthew E Call; Jason R Schnell; Chenqi Xu; Regina A Lutz; James J Chou; Kai W Wucherpfennig
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

10.  Catalytic water co-existing with a product peptide in the active site of HIV-1 protease revealed by X-ray structure analysis.

Authors:  Vishal Prashar; Subhash Bihani; Amit Das; Jean-Luc Ferrer; Madhusoodan Hosur
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.